Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China flag China · Delayed Price · Currency is CNY
5.94
-0.05 (-0.83%)
Sep 10, 2026, 3:00 PM CST

SHA:605199 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-403.86-287.37-274.4610.8585.6872.14
Depreciation & Amortization
100.4598.7377.8258.8851.0348.17
Other Amortization
3.182.681.630.830.540.31
Loss (Gain) From Sale of Assets
-0.270.05-0.040.080.010.09
Asset Writedown & Restructuring Costs
24.6712.740.86-0.541.83
Loss (Gain) From Sale of Investments
3.032.95-8.18-0.35-0.55-0.32
Provision & Write-off of Bad Debts
23.5823.584.0915.58-0.233.23
Other Operating Activities
57.6264.8244.4333.3522.8912.65
Change in Accounts Receivable
74.46-50.5617.8-63.98-245.05-34.15
Change in Inventory
159.12163.83-173.06-74.9-6.06-28.79
Change in Accounts Payable
122.75102.74165.4248.19326.920.38
Change in Other Net Operating Assets
-0.08-0.08----
Operating Cash Flow
167.19136.85-149.1228.25238.71102.48
Operating Cash Flow Growth
934.78%---88.17%132.93%3005.68%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-27.76-83.67-156.23-489.2-392.32-137.62
Sale of Property, Plant & Equipment
00.010.070.080.260.11
Cash Acquisitions
----35.1--
Divestitures
--13.68---
Investment in Securities
-----19.540.11
Investing Cash Flow
-27.76-83.66-142.48-524.21-411.6-117.1

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-592.9735.741,140686.02464.22
Long-Term Debt Repaid
--800.59-620.52-552.39-507.52-260.53
Lease Payments
-20.55-20.55-3.66-6.77-5.73-3.72
Net Debt Issued (Repaid)
-166.99-207.69115.22588.08178.5203.68
Common Dividends Paid
-31.83-33.55-92.16-31.56-14.35-73.75
Other Financing Activities
-54.07--1.23-3.47-16.38
Financing Cash Flow
-252.89-241.2521.83553.06164.15146.32

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-113.45-188.05-269.7757.1-8.74131.7

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
139.4353.18-305.35-460.95-153.61-35.14
Free Cash Flow Growth
------
Free Cash Flow Margin
21.99%5.90%-21.60%-25.68%-10.14%-2.60%
Free Cash Flow Per Share
0.290.13-0.77-1.27-0.38-0.09
Levered Free Cash Flow
386.8997.51-188.22-516.59-206.31-52.48
Unlevered Free Cash Flow
412.36122.97-168.37-505.19-195.06-43.81
Free Cash Flow After Leases
118.8832.63-309.01-467.71-159.35-38.86

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
43.7591.14147.75133.28138.47124.58
Change in Working Capital
358.8218.674.73-90.9878.81-35.62